AU2001288120A1 - Liquid prednisolone sodium phosphate preparation - Google Patents
Liquid prednisolone sodium phosphate preparationInfo
- Publication number
- AU2001288120A1 AU2001288120A1 AU2001288120A AU8812001A AU2001288120A1 AU 2001288120 A1 AU2001288120 A1 AU 2001288120A1 AU 2001288120 A AU2001288120 A AU 2001288120A AU 8812001 A AU8812001 A AU 8812001A AU 2001288120 A1 AU2001288120 A1 AU 2001288120A1
- Authority
- AU
- Australia
- Prior art keywords
- liquid
- sodium phosphate
- prednisolone sodium
- phosphate preparation
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000292633 | 2000-09-26 | ||
JP2000-292633 | 2000-09-26 | ||
PCT/JP2001/008304 WO2002026237A1 (en) | 2000-09-26 | 2001-09-25 | Liquid prednisolone sodium phosphate preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001288120A1 true AU2001288120A1 (en) | 2002-04-08 |
Family
ID=18775547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001288120A Abandoned AU2001288120A1 (en) | 2000-09-26 | 2001-09-25 | Liquid prednisolone sodium phosphate preparation |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP4860895B2 (en) |
AU (1) | AU2001288120A1 (en) |
WO (1) | WO2002026237A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109125256B (en) * | 2018-10-18 | 2020-10-27 | 江西国药有限责任公司 | Prednisolone injection and preparation method thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2655190B2 (en) * | 1989-06-21 | 1997-09-17 | エスエス製薬 株式会社 | Ointment containing corticosteroid |
JP3105009B2 (en) * | 1991-01-30 | 2000-10-30 | 帝國製薬株式会社 | Enema preparation |
JPH08503951A (en) * | 1992-12-02 | 1996-04-30 | インサイト・ビジョン・インコーポレイテッド | Drug delivery system using cyclodextrin and polymer |
TW389694B (en) * | 1995-08-17 | 2000-05-11 | Novartis Ag | Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics |
JPH1036253A (en) * | 1996-07-19 | 1998-02-10 | Showa Yakuhin Kako Kk | Aqueous suspended collyria |
JPH11189546A (en) * | 1997-12-25 | 1999-07-13 | Saitama Daiichi Seiyaku Kk | Percutaneous absorption promoter |
JPH11279065A (en) * | 1998-03-25 | 1999-10-12 | Shiseido Co Ltd | Inflammation treating agent for local administration |
-
2001
- 2001-09-25 JP JP2002530067A patent/JP4860895B2/en not_active Expired - Lifetime
- 2001-09-25 WO PCT/JP2001/008304 patent/WO2002026237A1/en active Application Filing
- 2001-09-25 AU AU2001288120A patent/AU2001288120A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPWO2002026237A1 (en) | 2004-02-05 |
JP4860895B2 (en) | 2012-01-25 |
WO2002026237A1 (en) | 2002-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001240115A1 (en) | Method for the preparation of tetrahydrobenzothiepines | |
AU1916599A (en) | Sachet formulations | |
AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
AU2002225855A1 (en) | Preparation of nanocrystallites | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU3192700A (en) | Medicinal compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU2001295657A1 (en) | Formulation containing wax-esters | |
AU2001263839A1 (en) | Liquid formulations | |
AU2001262691A1 (en) | Cosmetic preparation | |
AU2005300A (en) | Medicinal compositions | |
AU2001233208A1 (en) | Human sulfatases | |
AU2002214324A1 (en) | Medicinal compositions | |
AU2001290239A1 (en) | Medicinal composition | |
AU2001248833A1 (en) | Stable liquid preparation | |
AU2001281275A1 (en) | Processes for the preparation of oligonucleotides | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU2001245615A1 (en) | Pouched composition | |
AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
AU5469501A (en) | Proliposomal encapsulated preparation | |
AU2002212234A1 (en) | Stable ophthalmic preparation | |
AU2001256714A1 (en) | Water-based liquid preparation | |
AU1688099A (en) | Pharmaceutical preparation | |
AU2829700A (en) | Processes for the preparation of alpha-aminoketones | |
AU2001282521A1 (en) | OCT preparations |